Search results for "Prognosis."

showing 10 items of 2044 documents

Usefulness of regional right ventricular and right atrial strain for prediction of early and late right ventricular failure following a left ventricu…

2019

Background: Identifying candidates for left ventricular assist device surgery at risk of right ventricular failure remains difficult. The aim was to identify the most accurate predictors of right ventricular failure among clinical, biological, and imaging markers, assessed by agreement of different supervised machine learning algorithms. Methods: Seventy-four patients, referred to HeartWare left ventricular assist device since 2010 in two Italian centers, were recruited. Biomarkers, right ventricular standard, and strain echocardiography, as well as cath-lab measures, were compared among patients who did not develop right ventricular failure (N = 56), those with acute–right ventricular fail…

Malemedicine.medical_specialtyHeart Ventriclesmedicine.medical_treatmentBiomedical EngineeringMedicine (miscellaneous)heart failureBioengineeringStrain (injury)030204 cardiovascular system & hematologyRight atrialstrain imagingBiomaterials03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansechocardiographyAssisted CirculationHeart Atriacardiovascular diseases030212 general & internal medicinebusiness.industrySettore ING-IND/34 - Bioingegneria IndustrialeGeneral MedicineMiddle AgedPrognosismedicine.diseaseSettore MED/11 - Malattie Dell'Apparato Cardiovascolaremachine learningVentricular assist devicecardiovascular systemCardiologyRight ventricular failureRight ventricleFemaleHeart-Assist DevicesImplantbusiness
researchProduct

Functional Mitral Regurgitation Predicts Short-Term Adverse Events in Patients With Acute Heart Failure and Reduced Left Ventricular Ejection Fraction

2017

Functional mitral regurgitation (FMR) is a common finding in patients with acute heart failure (AHF) and reduced left ventricular ejection fraction (heart failure and reduced ejection fraction [HFrEF]). However, its clinical impact remains unclear. We aimed to evaluate the association between the severity of FMR after clinical stabilization and short-term adverse outcomes after a hospitalization for AHF. We prospectively included 938 consecutive patients with HFrEF discharged after a hospitalization for AHF, after excluding those with organic valve disease, congenital heart disease, or aortic valve disease. FMR was assessed semiquantitatively by color Doppler analysis of the regurgitant jet…

Malemedicine.medical_specialtyHeart diseaseHeart Ventricles030204 cardiovascular system & hematologyVentricular Function LeftElectrocardiography03 medical and health sciences0302 clinical medicineInternal medicinemedicineClinical endpointHumansIn patientProspective Studies030212 general & internal medicineAdverse effectProspective cohort studyAgedHeart FailureEjection fractionmedicine.diagnostic_testbusiness.industryMitral Valve InsufficiencyStroke VolumePrognosismedicine.diseaseEchocardiography DopplerSurvival RateSpainHeart failureAcute DiseaseCardiologyFemaleCardiology and Cardiovascular MedicinebusinessElectrocardiographyFollow-Up StudiesThe American Journal of Cardiology
researchProduct

Immuno-inflammatory predictors of stroke at follow-up in patients with chronic non-valvular atrial fibrillation (NVAF).

2009

Accumulating evidence suggests that inflammation plays an important role in the acute phase of ischemic stroke. CD40 L is a well recognized atherosclerotic inflammatory marker, whereas recent evidence suggests a pro-inflammatory role of Fetuin-A. To analyze the role of an inflammatory marker such as CD40 L and of a candidate pro-inflammatory marker such as Fetuin-A in acute stroke we evaluated their serum levels in subjects with acute ischemic stroke and their possible association with other laboratory and clinical variables. MATERIALS AND METHODS: We enrolled 107 consecutive patients with a diagnosis of acute ischemic stroke admitted to the Internal Medicine Department at the University of…

Malemedicine.medical_specialtyHeart diseaseImmuno-inflammatory predictorCentral nervous system diseaseVon Willebrand factorpatients with chronic non-valvular atrial fibrillationInternal medicineAtrial FibrillationMedicineHumansInterleukin 6StrokeAgedbiologyReceiver operating characteristicbusiness.industryVascular diseaseAtrial fibrillationGeneral MedicineMiddle Agedmedicine.diseasePrognosisSurgeryStrokeChronic Diseasebiology.proteinCardiologypredictors of strokeFemalebusinessEpidemiologic MethodsBiomarkers
researchProduct

Lung ultrasound in outpatients with heart failure: the wet‐to‐dry HF study

2021

The Nancy team is supported by the RHU Fight-HF, a public grant overseen by the French National Research Agency (ANR) as part of the second 'Investissements d'Avenir' programme (reference: ANR-15-RHUS-0004), by the French PIA project 'Lorraine Université d'Excellence' (reference: ANR-15-IDEX-04-LUE), the ANR FOCUS-MR (reference: ANR-15-CE14-0032-01), ERA-CVD EXPERT (reference: ANR-16-ECVD-0002-02), the Contrat de Plan Etat Lorraine IT2MP, and FEDER Lorraine. Aims: In ambulatory patients with chronic heart failure (HF), congestion and decongestion assessment may be challenging. The aim of this study is to assess the value of lung ultrasound (LUS) in outpatients with HF in characterizing deco…

Malemedicine.medical_specialtyHeart failure030204 cardiovascular system & hematologyPulmonary congestion03 medical and health sciences0302 clinical medicine[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemInterquartile rangeInternal medicineOutpatientsmedicineHumansDiseases of the circulatory (Cardiovascular) systemDecompensation030212 general & internal medicineLungUltrasonographyHeart FailureLung ultrasoundbusiness.industryHazard ratioOriginal ArticlesPrognosismedicine.diseaseConfidence interval[SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system3. Good healthLung ultrasoundRC666-701Heart failureAmbulatoryCardiologyOriginal ArticleFemaleCardiology and Cardiovascular MedicinebusinessAfter treatmentESC Heart Failure
researchProduct

Biochemical risk indices, including plasma homocysteine, that prospectively predict mortality in older British people: the National Diet and Nutritio…

2010

Predictive power, for total and vascular mortality, of selected indices measured at baseline in the British National Diet and Nutrition Survey (community-living subset) of People Aged 65 Years and Over was tested. Mortality status and its primary and underlying causes were recorded for 1100 (mean age 76·7 (sd7·5) years, 50·2 % females) respondents from the baseline survey in 1994–5 until September 2008. Follow-up data analyses focussed especially on known predictors of vascular disease risk, together with intakes and status indices of selected nutrients known to affect, or to be affected by, these predictors. Total mortality was significantly predicted by hazard ratios of baseline plasma co…

Malemedicine.medical_specialtyHomocysteineMedicine (miscellaneous)Nutritional StatusDiet SurveysArticlechemistry.chemical_compoundRisk FactorsInternal medicineMedicineChymotrypsinHumansVitamin B12Vascular DiseasesRisk factorMortalityHomocysteineSurvival analysisAgedProportional Hazards ModelsAged 80 and overGlycated HemoglobinCreatinineNutrition and Dieteticsbusiness.industryProportional hazards modelHazard ratioFibrinogenPrognosisSurvival AnalysisUnited KingdomB vitaminsEndocrinologyCholesterolchemistryCreatinineVitamin B ComplexFemaleDietary ProteinsbusinessEnergy IntakeBiomarkersDemographyThe British journal of nutrition
researchProduct

Comparison between euglycemic hyperinsulinemic clamp and surrogate indices of insulin sensitivity in children with growth hormone deficiency

2018

Objective: Data about the impact of growth hormone treatment (GHT) on insulin sensitivity in children are quite controversial, due to the different surrogate indices that have been used. Design: We evaluated insulin sensitivity through the euglycemic hyperinsulinemic clamp, considered the gold standard technique, in 23 children affected by growth hormone deficiency (GHD) at baseline and after 12. months of GHT and in 12 controls with short stature at baseline, and we compared the clamp-derived index (M-value) with the most commonly used surrogate index of insulin sensitivity, as ISI Matsuda, and with circulating plasma markers of insulin sensitivity, as adiponectin and resistin levels. Resu…

Malemedicine.medical_specialtyHormone Replacement TherapyEndocrinology Diabetes and Metabolism030209 endocrinology & metabolismShort statureGrowth hormone deficiencySettore MED/13 - Endocrinologia03 medical and health sciences0302 clinical medicineEndocrinologyInternal medicineGlucose IntolerancemedicineHumansResistinProspective StudiesChildGrowth DisordersEuglycemic hyperinsulinemic clampAdiponectinHuman Growth Hormonebusiness.industryGrowth hormone deficiency; Hyperinsulinemic clamp; Insulin sensitivity; Endocrinology Diabetes and Metabolism; EndocrinologyInsulin sensitivityHyperinsulinemic clampGold standard (test)Glucose Tolerance TestPrognosismedicine.diseaseInsulin sensitivityGrowth hormone treatmentEndocrinologyCase-Control Studies030220 oncology & carcinogenesisGlucose Clamp TechniqueFemaleResistinGrowth hormone deficiencyAdiponectinInsulin Resistancemedicine.symptombusinessBiomarkersFollow-Up Studies
researchProduct

Interstitial Lung Disease in Elderly Rheumatoid Arthritis Patients

2019

The increase in life expectancy together with better care of rheumatoid arthritis (RA) has led to higher proportions of elderly individuals with RA. This has challenged the treatment of the disease in older aged patients, usually characterized by comorbid conditions and polypharmacy. Overall, the lung involvement in RA is present in up to 80% of patients, depending on the assessment tools used, and interstitial abnormalities are among the most common; when present, interstitial lung disease (ILD) worsens the prognosis of RA, and is the second most common cause of mortality. The aged lung undergoes functional and structural changes termed immunosenescence and inflammaging, which facilitate t…

Malemedicine.medical_specialtyImmunosenescenceArthritisDiseaseSettore MED/10 - Malattie Dell'Apparato RespiratorioInterstitial Lung Disease Rheumatoid ArthritisArthritis Rheumatoid03 medical and health sciences0302 clinical medicineUsual interstitial pneumoniaRisk FactorsInternal medicinemedicineHumansPharmacology (medical)030212 general & internal medicineAgedPolypharmacyLungbusiness.industryIncidenceInterstitial lung diseaseImmunosenescencerespiratory systemMiddle Agedmedicine.diseasePrognosisrespiratory tract diseasesSettore MED/16 - Reumatologiamedicine.anatomical_structureRheumatoid arthritisAntirheumatic AgentsFemaleGeriatrics and GerontologybusinessLung Diseases InterstitialTomography X-Ray Computed030217 neurology & neurosurgery
researchProduct

Validation of the histologic risk model in a new cohort of patients with head and neck squamous cell carcinoma.

2010

Background: Half of the patients with head and neck squamous cell carcinoma (HNSCC) can be expected to fail therapy, indicating that more aggressive treatment is warranted for this group. We have developed a novel risk model that can become a basis for developing new treatment paradigms. Here we report on the performance of our model in a new multicenter cohort. Design: Eligible patients from 3 institutions (Montefiore Medical Center, University of Manitoba, and New York University Medical Center) were identified and pathology slides from their resection specimens were reviewed by Margaret Brandwein-Gensler; risk category was assigned as previously published. Kaplan-Meier analysis was perfo…

Malemedicine.medical_specialtyKaplan-Meier EstimatePathology and Forensic MedicineRisk FactorsInternal medicinemedicineHumansRisk factorProportional Hazards Modelsbusiness.industryHead and neck cancerHazard ratioReproducibility of ResultsManitobaMiddle Agedmedicine.diseasePrognosisHead and neck squamous-cell carcinomaConfidence intervalSurgerySurvival RateEpidermoid carcinomaHead and Neck NeoplasmsCohortCarcinoma Squamous CellSurgeryFemaleNew York CityAnatomybusinessCohort studyThe American journal of surgical pathology
researchProduct

A randomized, intraindividual, non-inferiority, Phase III study comparing daylight photodynamic therapy with BF-200 ALA gel and MAL cream for the tre…

2018

Abstract Background The most effective treatment modality for actinic keratosis (AK) is photodynamic therapy (PDT). Major obstacles of PDT are the need of a special illumination device and pain accompanying the illumination. These issues may be overcome by replacing an artificial high‐power light source with natural daylight for more extended illumination at lower light doses. Objective To determine whether BF‐200 ALA (a nanoemulsion gel containing 7.8% 5‐aminolaevulinic acid) is non‐inferior to MAL (a cream containing 16% methyl‐aminolaevulinate) in the treatment of mild‐to‐moderate AK with daylight PDT (dPDT). Non‐inferiority of the primary efficacy variable (total lesion clearance rate p…

Malemedicine.medical_specialtyKeratosisgenetic structuresOriginal Articles and Short Reports Oncologymedicine.medical_treatmentUrologySkin CreamPhotodynamic therapyDermatologyAdministration CutaneousSeverity of Illness IndexStatistics Nonparametriclaw.inventionLesion030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineRandomized controlled triallawGermanySeverity of illnessmedicineClinical endpointHumansAgedPhotosensitizing Agentsbusiness.industryActinic keratosisAminolevulinic Acidmedicine.diseasePrognosisClinical trialKeratosis ActinicInfectious DiseasesTreatment OutcomePhotochemotherapySpain030220 oncology & carcinogenesisFemaleOriginal Articlemedicine.symptombusinessGelsJournal of the European Academy of Dermatology and Venereology : JEADV
researchProduct

Stroke in diabetic patients.

2011

Stroke is the leading cause of disability and the second most frequent cause of death worldwide. On the one hand, diabetic patients have a 1.5 to 3-times higher risk of stroke, especially cerebral infarction, than non-diabetic subjects. This excess risk, which is particularly pronounced in younger individuals and women, can be reduced by effective therapeutic strategies aimed at improving glycaemic control and the management of co-morbid conditions such as hypertension and dyslipidaemia. On the other hand, the prevalence of diabetes in stroke patients is between 10 and 20%, and has been increasing over the last 20 years, probably in response to rising rates of overweight and obesity in the …

Malemedicine.medical_specialtyLacunar strokeEndocrinology Diabetes and MetabolismPopulationDiabetes ComplicationsEndocrinologyRisk FactorsInternal medicineDiabetes mellitusInternal MedicinemedicineHumanscardiovascular diseasesRisk factoreducationStrokeCause of deatheducation.field_of_studybusiness.industryCerebral infarctionAbsolute risk reductionGeneral Medicinemedicine.diseasePrognosisStrokePhysical therapyFemalebusinessDiabetesmetabolism
researchProduct